Skip to content

Eli Lilly LLY Free cash flow

Free cash flow at other companies

Pfizer logo
PfizerPFE
$2.18B+23.0%
Amgen logo
AmgenAMGN
$1.48B+50.7%
Cardinal Health logo
Cardinal HealthCAH
$1.68B-40.0%
Biogen logo
BiogenBIIB
$594.3M+167%
Mannkind logo
MannkindMNKD
-$7.25M-8.0%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-$23.65M-13.3%

Other financials

Income statement

See full
Revenue$19.8B+55.5%
Gross profit$16.2B+54.4%
Net income$7.4B+168%
EPS (diluted)$8.26+170%

Balance sheet

See full
Cash & equivalents$5.3B+70.8%
Total debt$43.4B+12.6%
Total equity$31.2B+97.9%
Total assets$116.58B+30.4%

Cash flow

See full
Operating cash flow$5.3B+220%
CapEx$2.3B+54.0%

Valuation

See full
Market cap$1.01T+46.9%
Enterprise value$1.04T+44.9%
P/E39.8×-21.9×
P/S13.9×-0.1×

Profitability

See full
Gross margin82.8%+1.1pp
Net margin35%+12.3pp
FCF margin16.4%+8.7pp

Returns & leverage

See full
Return on equity107.6%+29.9pp
Debt / equity1.4×-1.1×
Current ratio1.5×+0.1×

Where this comes from

Calculated from Eli Lilly’s reported figures.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eli Lilly's free cash flow?
Eli Lilly (LLY) reported free cash flow of $3.01B in Q1 2026.
How has Eli Lilly's free cash flow changed year-over-year?
Eli Lilly's free cash flow increased by 1827.6% year-over-year, from $156M to $3.01B.
What is the long-term trend for Eli Lilly's free cash flow?
Over 3 years (2021 to 2025), Eli Lilly's free cash flow has grown at a 14.0% compound annual growth rate (CAGR), from $6.06B to $8.97B.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.